Danon Disease Natural History Study
Part of paid clinical trials in Phoenix, Arizona.
- Sponsor
- Rocket Pharmaceuticals Inc.
- Study ID
- NCT06214507
- Status
- Recruiting
Conditions
- Danon Disease
Eligibility Criteria
- Sex
- ALL
- Age
- 8 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- No intervention — OTHERNo intervention
Study Details
The goal of this international observational study is to learn about the natural history of Danon disease in male patients (≥8 years of age) and female patients (8 to 50 years of age).
Key Dates
- Start date
- Dec 20, 2023
- Status verified
- Apr 2026
- Primary completion
- Dec 31, 2029
- Completion
- Mar 31, 2030
Study Design
- Enrollment
- 60 participants (estimated)
Arms
- Arm: Prospective Cohort
- Arm: Retrospective Cohort
Primary Outcome Measure
Left Ventricular Mass Index (LVMI) by echocardiogram [ Time Frame: Month 12, 24, 36 ]
Central Contacts
- Clinical Information646-627-0033
Locations (8)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Phoenix Children's Hospital | Phoenix | Arizona | 85016 | Andrew Papez, MD (PRINCIPAL_INVESTIGATOR) |
| University of California, San Diego | La Jolla | California | 92037 | Kimberly Hong, MD (PRINCIPAL_INVESTIGATOR) |
| Children's Hospital Colorado | Aurora | Colorado | 80045 | Matthew Taylor, MD (PRINCIPAL_INVESTIGATOR) |
| University of Florida College of Medicine | Gainesville | Florida | 32610 | Mohammed M Ahmed, MD (PRINCIPAL_INVESTIGATOR) |
| University of Michigan | Ann Arbor | Michigan | 48109 | Supriya Shore Supriya Shore, MD (PRINCIPAL_INVESTIGATOR) Josh Meisner, MD (SUB_INVESTIGATOR) |
| Washington University | St Louis | Missouri | 63110 | Charles Canter, MD (PRINCIPAL_INVESTIGATOR) |
| Columbia University Medical Center/New York Presbyterian | New York | New York | 10032 | Jessica Idumonyi Farhana Latif, MD (PRINCIPAL_INVESTIGATOR) |
| Texas Children's Hospital | Houston | Texas | 77030 | Kyle Hope, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Phoenix, AZ
Related Studies
- A Gene Therapy Study of RP-A501 in Male Patients With Danon DiseasePHASE2 · Recruiting · Rocket Pharmaceuticals Inc. · La Jolla, California
- Rare Glycogen Storage Diseases Natural History StudyRecruiting · Duke University · Durham, North Carolina